NewGenIvf Group Ltd - Warrants (03/04/2029)'s EBIT is $9.6M, above the sector sector average of $-22M.
Get informed when a big investor buys or sells
+ FollowAs of Dec 31, 2025
Trailing 12 months ending Dec 31, 2025
As of the most recent data (December 2025), NIVFW shows a EBIT of $9.6M. That compares with $-2.5M in the prior-year period — up 481.4% year over year. That is above the sector sector average of $-22M. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, NIVFW's EBIT is now $9.6M (was $-2.5M) — a 481.4% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether NewGenIvf Group Ltd - Warrants (03/04/2029) is outperforming or lagging.
The its sector sector average EBIT is about $-22M. NewGenIvf Group Ltd - Warrants (03/04/2029) is at $9.6M, which is higher that average. That is roughly 143.8% above the sector mean. Use the comparison chart on this page to see how NIVFW stacks up against individual peers as well.
Tracking NIVFW's ebit over time shows whether NewGenIvf Group Ltd - Warrants (03/04/2029) is scaling, shrinking, or reshaping that part of the business. The current reading is $9.6M That compares with $-2.5M in the prior-year period — up 481.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this ebit page, Stockcircle has NewGenIvf Group Ltd - Warrants (03/04/2029)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $9.6M) with ownership activity and broader fundamentals.